"Know your enemy," Sun Tzu, the great sage of war, wrote some 2,500 years ago. Today, as COVID-19 spreads around the globe, the greatest army of medical scientists ever assembled is bent on learning all it can, as fast as ...
Sep 10, 2020
0
5
New research suggests that a different approach to modelling the spread of the novel coronavirus that causes COVID-19, SARS-CoV-2, could be beneficial for developing new strategies for coping with the ongoing global pandemic. ...
May 19, 2020
0
0
As the end of the second world war neared, mass production of the newly developed antibiotic penicillin enabled life-saving treatment of bacterial infections in wounded soldiers. Since then, penicillin and many other antibiotics ...
May 8, 2020
0
5
As the COVID-19 pandemic spreads, it has become clear that people need to understand basic facts about SARS-CoV-2, the virus that causes COVID-19, to make informed health care and public policy decisions. Two basic virological ...
Apr 15, 2020
0
5
Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. Although there is a vaccine that offers protection against the virus, current treatments which prevent the virus from replicating are not ...
Apr 9, 2019
0
22
Vaccines designed to protect people from the influenza virus tend to concentrate on hemagglutinin, one of the two prominently displayed proteins on the surface of the virus and the primary target for influenza prevention.
Apr 5, 2018
0
65
The ability of HIV to mutate has been a major challenge to vaccine development. As the body produces antibodies to target the outer HIV envelope protein, this protein changes, thwarting the circulating antibodies' ability ...
Jan 17, 2018
0
31
Worldwide, four in five adults are infected with herpes simplex virus (HSV), say researchers. But most of those infected don't show symptoms like cold sores because the virus infection is "latent" or "silent"—sleeping—within ...
Oct 26, 2017
0
3
With the successful suppression of the AIDS virus (HIV) through medication, the focus turns toward its eradication. Researchers from Kumamoto University in Japan have developed a new compound that is key to the destruction ...
Oct 2, 2017
0
632
(HealthDay)—The amplitude of therapeutic revascularization associated with recombinant adeno-associated virus (rAAV) (5 × 1012 viral particles encoding thymosin beta 4 [Tβ4]) is reduced with diabetes mellitus, according ...
Jan 10, 2017
0
0
